Privium Fund Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
2025
Q3
$581K Hold
2025
Q2
$610K Hold
2025
Q1
$630K Hold
2024
Q4
$804K Buy
2024
Q3
$514K Buy
2024
Q2
$372K Buy